Board members buys additional shares in Scandinavian ChemoTech AB
Scandinavian ChemoTech AB (publ) (“ChemoTech”) announces today that Bengt Engström, board member, has bought 5,000 shares for approximately SEK 162,500 over the stock exchange. His total holding now amounts to 43,000 shares in ChemoTech. Rolf Ehrnström, board member, has bought 10,000 shares for approximately SEK 326,000 over the stock exchange. His total holding now amounts to 20,000 shares in ChemoTech.
“Last week, ChemoTech received CE marking for its system IQwave & TSE (tumour specific electroporation). It was of course an important part of our development, but at the same time only